語系:
繁體中文
English
說明(常見問題)
回圖書館首頁
手機版館藏查詢
登入
回首頁
切換:
標籤
|
MARC模式
|
ISBD
Controversial statistical issues in ...
~
Chow, Shein-Chung, (1955-)
FindBook
Google Book
Amazon
博客來
Controversial statistical issues in clinical trials
紀錄類型:
書目-電子資源 : Monograph/item
正題名/作者:
Controversial statistical issues in clinical trials/ Shein-Chung Chow.
作者:
Chow, Shein-Chung,
出版者:
Boca Raton :CRC Press, : c2011.,
面頁冊數:
1 online resource (xix, 591 p.) :ill.
標題:
Drugs - Testing. -
電子資源:
http://www.crcnetbase.com/isbn/9781439849620
ISBN:
9781439849620 (electronic bk.)
Controversial statistical issues in clinical trials
Chow, Shein-Chung,1955-
Controversial statistical issues in clinical trials
[electronic resource] /Shein-Chung Chow. - Boca Raton :CRC Press,c2011. - 1 online resource (xix, 591 p.) :ill. - Chapman & Hall/CRC biostatistics series. - Chapman & Hall/CRC biostatistics series..
Includes bibliographical references (p. 553-575) and index.
"Preface In pharmaceutical/clinical development of a test drug or treatment, relevant clinical data are usually collected from subjects with the diseases under study in order to evaluate safety and efficacy of the test drug or treatment under investigation. To provide accurate and reliable assessment, well-controlled clinical trials under valid study design are necessarily conducted. Clinical trial process is a lengthy and costly process, which is necessary to ensure a fair and reliable assessment of the test treatment under investigation. Clinical trial process consists of protocol development, trial conduct, data collection, statistical analysis/interpretation, and reporting. In practice, controversial issues evitably occur regardless the compliance of good statistical practice (GSP) and good clinical practice (GCP). Controversial issues in clinical trials are referred to as debatable issues that are commonly encountered during the conduct of clinical trials. In practice, controversial issues could be raised from, but are not limited to, (1) compromises between theoretical and real/common practices, (2) miscommunication and/or misunderstanding in perception/interpretation among regulatory agencies, clinical scientists, and biostatisticians, and (3) disagreement, inconsistency, miscommunication/misunderstanding, and errors in clinical practice. "--
ISBN: 9781439849620 (electronic bk.)
LCCN: 2011024204Subjects--Topical Terms:
646233
Drugs
--Testing.
LC Class. No.: RM301.27 / .C475 2011
Dewey Class. No.: 615.5072/4
National Library of Medicine Call No.: QV 771
Controversial statistical issues in clinical trials
LDR
:02335cmm a2200277 a 4500
001
2034071
005
20150206143227.0
006
m o d
007
cr |n|---|||||
008
161104s2011 flua ob 001 0 eng
010
$a
2011024204
020
$a
9781439849620 (electronic bk.)
020
$z
9781439849613 (hardback)
035
$a
(DNLM)101562559
035
$a
16827822
040
$a
DNLM/DLC
$c
DLC
$d
DLC
050
0 0
$a
RM301.27
$b
.C475 2011
060
1 0
$a
QV 771
082
0 0
$a
615.5072/4
$2
23
100
1
$a
Chow, Shein-Chung,
$d
1955-
$3
646840
245
1 0
$a
Controversial statistical issues in clinical trials
$h
[electronic resource] /
$c
Shein-Chung Chow.
260
$a
Boca Raton :
$b
CRC Press,
$c
c2011.
300
$a
1 online resource (xix, 591 p.) :
$b
ill.
490
1
$a
Chapman & Hall/CRC biostatistics series
504
$a
Includes bibliographical references (p. 553-575) and index.
520
$a
"Preface In pharmaceutical/clinical development of a test drug or treatment, relevant clinical data are usually collected from subjects with the diseases under study in order to evaluate safety and efficacy of the test drug or treatment under investigation. To provide accurate and reliable assessment, well-controlled clinical trials under valid study design are necessarily conducted. Clinical trial process is a lengthy and costly process, which is necessary to ensure a fair and reliable assessment of the test treatment under investigation. Clinical trial process consists of protocol development, trial conduct, data collection, statistical analysis/interpretation, and reporting. In practice, controversial issues evitably occur regardless the compliance of good statistical practice (GSP) and good clinical practice (GCP). Controversial issues in clinical trials are referred to as debatable issues that are commonly encountered during the conduct of clinical trials. In practice, controversial issues could be raised from, but are not limited to, (1) compromises between theoretical and real/common practices, (2) miscommunication and/or misunderstanding in perception/interpretation among regulatory agencies, clinical scientists, and biostatisticians, and (3) disagreement, inconsistency, miscommunication/misunderstanding, and errors in clinical practice. "--
$c
Provided by publisher.
588
$a
Description based on print version record.
650
0
$a
Drugs
$x
Testing.
$3
646233
650
0
$a
Drug development.
$3
716904
650
0
$a
Clinical trials.
$3
724498
650
1 2
$a
Clinical Trials as Topic.
$3
1074953
650
1 2
$a
Drug Evaluation, Preclinical.
$3
752567
650
2 2
$a
Data Interpretation, Statistical.
$3
646414
830
0
$a
Chapman & Hall/CRC biostatistics series.
$3
2018655
856
4 0
$u
http://www.crcnetbase.com/isbn/9781439849620
筆 0 讀者評論
館藏地:
全部
電子資源
出版年:
卷號:
館藏
1 筆 • 頁數 1 •
1
條碼號
典藏地名稱
館藏流通類別
資料類型
索書號
使用類型
借閱狀態
預約狀態
備註欄
附件
W9279093
電子資源
11.線上閱覽_V
電子書
EB RM301.27 .C475 2011
一般使用(Normal)
在架
0
1 筆 • 頁數 1 •
1
多媒體
評論
新增評論
分享你的心得
Export
取書館
處理中
...
變更密碼
登入